diazoxide has been researched along with Chondrosarcoma in 1 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Chondrosarcoma: A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diazoxide treatment also modulated the expression levels of OA-related biomarkers." | 5.48 | Diazoxide ameliorates severity of experimental osteoarthritis by activating autophagy via modulation of the osteoarthritis-related biomarkers. ( Bian, Y; Chen, K; Cheng, S; Fu, J; Gu, Y; Meng, Z; Peng, L; Shen, B; Wu, Z; Yao, J; Zeng, D; Zhao, Y, 2018) |
| "Diazoxide treatment also modulated the expression levels of OA-related biomarkers." | 1.48 | Diazoxide ameliorates severity of experimental osteoarthritis by activating autophagy via modulation of the osteoarthritis-related biomarkers. ( Bian, Y; Chen, K; Cheng, S; Fu, J; Gu, Y; Meng, Z; Peng, L; Shen, B; Wu, Z; Yao, J; Zeng, D; Zhao, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, Z | 1 |
| Shen, B | 1 |
| Gu, Y | 1 |
| Wu, Z | 1 |
| Yao, J | 1 |
| Bian, Y | 1 |
| Zeng, D | 1 |
| Chen, K | 1 |
| Cheng, S | 1 |
| Fu, J | 1 |
| Peng, L | 1 |
| Zhao, Y | 1 |
1 other study available for diazoxide and Chondrosarcoma
| Article | Year |
|---|---|
Diazoxide ameliorates severity of experimental osteoarthritis by activating autophagy via modulation of the osteoarthritis-related biomarkers.
Topics: ADAMTS5 Protein; Animals; Autophagy; Biomarkers; Blotting, Western; Cell Survival; Chondrosarcoma; C | 2018 |